insights_auto
Why is EDIT down 4.15%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$2.08
arrow_downward
-4.15%(-0.090) 1D
Nov 16, 9:34:54 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.10
High
$2.12
Low
$2.06
Mkt. cap
321.03M
Avg. vol.
2.44M
Volume
8.97K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$2.10
High
$2.12
Low
$2.06
Mkt. cap
321.03M
Avg. vol.
2.44M
Volume
8.97K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Premarket Losers on Nov. 16, 2026: COIN, LITE, COHR
Kitco
·
2 hours ago
S&P 500, Nasdaq futures fall ahead of Nvidia earnings, Anthropic IPO
Crypto News
·
3 hours ago
Bitget launches rToken Earn for tokenized S&P 500, Nasdaq-100 ETFs
FXEmpire
·
1 hour ago
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com